Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Program Projects (P01)
Project #
5P01HD026927-08
Application #
6138767
Study Section
Mental Retardation Research Committee (HDMR)
Program Officer
Hanson, James W
Project Start
1991-04-01
Project End
2001-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
8
Fiscal Year
2000
Total Cost
$658,299
Indirect Cost
Name
University of Kansas Lawrence
Department
Pediatrics
Type
Organized Research Units
DUNS #
072933393
City
Lawrence
State
KS
Country
United States
Zip Code
66045
Hellings, Jessica A; Zarcone, Jennifer R; Reese, R Matthew et al. (2006) A crossover study of risperidone in children, adolescents and adults with mental retardation. J Autism Dev Disord 36:401-11
Hellings, Jessica A (2006) Much improved outcome with gabapentin-divalproex combination in adults with bipolar disorders and developmental disabilities. J Clin Psychopharmacol 26:344-6
Hellings, Jessica A; Nickel, Elizabeth J; Weckbaugh, Marilyn et al. (2005) The overt aggression scale for rating aggression in outpatient youth with autistic disorder: preliminary findings. J Neuropsychiatry Clin Neurosci 17:29-35
Saunders, Richard R; McEntee, Julie E; Saunders, Muriel D (2005) Interaction of reinforcement schedules, a behavioral prosthesis, and work-related behavior in adults with mental retardation. J Appl Behav Anal 38:163-76
Hellings, Jessica A; Weckbaugh, Marilyn; Nickel, Elizabeth J et al. (2005) A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol 15:682-92
Hellings, Jessica A; Zarcone, Jennifer R; Valdovinos, Maria G et al. (2005) Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders. J Child Adolesc Psychopharmacol 15:885-92
Valdovinos, M G; Zarcone, J R; Hellings, J A et al. (2004) Using the Diagnostic Assessment of the Severely Handicapped-II (DASH-II) to measure the therapeutic effects of risperidone. J Intellect Disabil Res 48:53-9
Yoo, J Helen; Williams, Dean C; Napolitano, Deborah A et al. (2003) Rate-decreasing effects of the atypical neuroleptic risperidone attenuated by conditions of reinforcement in a woman with mental retardation. J Appl Behav Anal 36:245-8
Crosland, Kimberly A; Zarcone, Jennifer R; Lindauer, Steven E et al. (2003) Use of functional analysis methodology in the evaluation of medication effects. J Autism Dev Disord 33:271-9
Hellings, Jessica A; Hossain, Shaheena; Martin, Judy K et al. (2002) Psychopathology, GABA, and the Rubinstein-Taybi syndrome: a review and case study. Am J Med Genet 114:190-5

Showing the most recent 10 out of 28 publications